Global and China Metastatic Prostate Cancer Treatment Market Size, Status and Forecast 2024-2031

Report ID: 1025096 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Metastatic Prostate Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Mono
        1.2.3 Combination
        1.2.4 Mono/Combination
    1.3 Market by Application
        1.3.1 Global Metastatic Prostate Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Drug Store
        1.3.4 Online Pharmacy
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Metastatic Prostate Cancer Treatment Market Perspective (2016-2027)
    2.2 Metastatic Prostate Cancer Treatment Growth Trends by Regions
        2.2.1 Metastatic Prostate Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Metastatic Prostate Cancer Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Metastatic Prostate Cancer Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Metastatic Prostate Cancer Treatment Industry Dynamic
        2.3.1 Metastatic Prostate Cancer Treatment Market Trends
        2.3.2 Metastatic Prostate Cancer Treatment Market Drivers
        2.3.3 Metastatic Prostate Cancer Treatment Market Challenges
        2.3.4 Metastatic Prostate Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Metastatic Prostate Cancer Treatment Players by Revenue
        3.1.1 Global Top Metastatic Prostate Cancer Treatment Players by Revenue (2016-2021)
        3.1.2 Global Metastatic Prostate Cancer Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Metastatic Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Metastatic Prostate Cancer Treatment Revenue
    3.4 Global Metastatic Prostate Cancer Treatment Market Concentration Ratio
        3.4.1 Global Metastatic Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Metastatic Prostate Cancer Treatment Revenue in 2020
    3.5 Metastatic Prostate Cancer Treatment Key Players Head office and Area Served
    3.6 Key Players Metastatic Prostate Cancer Treatment Product Solution and Service
    3.7 Date of Enter into Metastatic Prostate Cancer Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Metastatic Prostate Cancer Treatment Breakdown Data by Type
    4.1 Global Metastatic Prostate Cancer Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Metastatic Prostate Cancer Treatment Breakdown Data by Application
    5.1 Global Metastatic Prostate Cancer Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Metastatic Prostate Cancer Treatment Market Size (2016-2027)
    6.2 North America Metastatic Prostate Cancer Treatment Market Size by Type
        6.2.1 North America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
        6.2.2 North America Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
        6.2.3 North America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
    6.3 North America Metastatic Prostate Cancer Treatment Market Size by Application
        6.3.1 North America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
        6.3.2 North America Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
        6.3.3 North America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
    6.4 North America Metastatic Prostate Cancer Treatment Market Size by Country
        6.4.1 North America Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021)
        6.4.2 North America Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Metastatic Prostate Cancer Treatment Market Size (2016-2027)
    7.2 Europe Metastatic Prostate Cancer Treatment Market Size by Type
        7.2.1 Europe Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
    7.3 Europe Metastatic Prostate Cancer Treatment Market Size by Application
        7.3.1 Europe Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
    7.4 Europe Metastatic Prostate Cancer Treatment Market Size by Country
        7.4.1 Europe Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type
        8.2.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application
        8.3.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region
        8.4.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Metastatic Prostate Cancer Treatment Market Size (2016-2027)
    9.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Type
        9.2.1 Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
    9.3 Latin America Metastatic Prostate Cancer Treatment Market Size by Application
        9.3.1 Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
    9.4 Latin America Metastatic Prostate Cancer Treatment Market Size by Country
        9.4.1 Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type
        10.2.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application
        10.3.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country
        10.4.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AB Science
        11.1.1 AB Science Company Details
        11.1.2 AB Science Business Overview
        11.1.3 AB Science Metastatic Prostate Cancer Treatment Introduction
        11.1.4 AB Science Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
        11.1.5 AB Science Recent Development
    11.2 BeiGene
        11.2.1 BeiGene Company Details
        11.2.2 BeiGene Business Overview
        11.2.3 BeiGene Metastatic Prostate Cancer Treatment Introduction
        11.2.4 BeiGene Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
        11.2.5 BeiGene Recent Development
    11.3 eFFECTOR Therapeutics
        11.3.1 eFFECTOR Therapeutics Company Details
        11.3.2 eFFECTOR Therapeutics Business Overview
        11.3.3 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Introduction
        11.3.4 eFFECTOR Therapeutics Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
        11.3.5 eFFECTOR Therapeutics Recent Development
    11.4 Immunomedics(Gilead Sciences, Inc.)
        11.4.1 Immunomedics(Gilead Sciences, Inc.) Company Details
        11.4.2 Immunomedics(Gilead Sciences, Inc.) Business Overview
        11.4.3 Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Introduction
        11.4.4 Immunomedics(Gilead Sciences, Inc.) Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
        11.4.5 Immunomedics(Gilead Sciences, Inc.) Recent Development
    11.5 Myovant Biosciences
        11.5.1 Myovant Biosciences Company Details
        11.5.2 Myovant Biosciences Business Overview
        11.5.3 Myovant Biosciences Metastatic Prostate Cancer Treatment Introduction
        11.5.4 Myovant Biosciences Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
        11.5.5 Myovant Biosciences Recent Development
    11.6 SeleXel
        11.6.1 SeleXel Company Details
        11.6.2 SeleXel Business Overview
        11.6.3 SeleXel Metastatic Prostate Cancer Treatment Introduction
        11.6.4 SeleXel Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
        11.6.5 SeleXel Recent Development
    11.7 Zenith Epigenetics Ltd.
        11.7.1 Zenith Epigenetics Ltd. Company Details
        11.7.2 Zenith Epigenetics Ltd. Business Overview
        11.7.3 Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Introduction
        11.7.4 Zenith Epigenetics Ltd. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
        11.7.5 Zenith Epigenetics Ltd. Recent Development
    11.8 VasGene Therapeutics, Inc.
        11.8.1 VasGene Therapeutics, Inc. Company Details
        11.8.2 VasGene Therapeutics, Inc. Business Overview
        11.8.3 VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Introduction
        11.8.4 VasGene Therapeutics, Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
        11.8.5 VasGene Therapeutics, Inc. Recent Development
    11.9 Telix Pharmaceuticals
        11.9.1 Telix Pharmaceuticals Company Details
        11.9.2 Telix Pharmaceuticals Business Overview
        11.9.3 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Introduction
        11.9.4 Telix Pharmaceuticals Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
        11.9.5 Telix Pharmaceuticals Recent Development
    11.10 Arvinas Inc.
        11.10.1 Arvinas Inc. Company Details
        11.10.2 Arvinas Inc. Business Overview
        11.10.3 Arvinas Inc. Metastatic Prostate Cancer Treatment Introduction
        11.10.4 Arvinas Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
        11.10.5 Arvinas Inc. Recent Development
    11.11 Amgen
        11.11.1 Amgen Company Details
        11.11.2 Amgen Business Overview
        11.11.3 Amgen Metastatic Prostate Cancer Treatment Introduction
        11.11.4 Amgen Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
        11.11.5 Amgen Recent Development
    11.12 Genentech
        11.12.1 Genentech Company Details
        11.12.2 Genentech Business Overview
        11.12.3 Genentech Metastatic Prostate Cancer Treatment Introduction
        11.12.4 Genentech Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
        11.12.5 Genentech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Metastatic Prostate Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Mono
    Table 3. Key Players of Combination
    Table 4. Key Players of Mono/Combination
    Table 5. Global Metastatic Prostate Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Metastatic Prostate Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Metastatic Prostate Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Metastatic Prostate Cancer Treatment Market Share by Regions (2016-2021)
    Table 9. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Metastatic Prostate Cancer Treatment Market Share by Regions (2022-2027)
    Table 11. Metastatic Prostate Cancer Treatment Market Trends
    Table 12. Metastatic Prostate Cancer Treatment Market Drivers
    Table 13. Metastatic Prostate Cancer Treatment Market Challenges
    Table 14. Metastatic Prostate Cancer Treatment Market Restraints
    Table 15. Global Metastatic Prostate Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Metastatic Prostate Cancer Treatment Market Share by Players (2016-2021)
    Table 17. Global Top Metastatic Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Prostate Cancer Treatment as of 2020)
    Table 18. Ranking of Global Top Metastatic Prostate Cancer Treatment Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Metastatic Prostate Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Metastatic Prostate Cancer Treatment Product Solution and Service
    Table 22. Date of Enter into Metastatic Prostate Cancer Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2016-2021)
    Table 26. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Metastatic Prostate Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Application (2016-2021)
    Table 30. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. AB Science Company Details
    Table 63. AB Science Business Overview
    Table 64. AB Science Metastatic Prostate Cancer Treatment Product
    Table 65. AB Science Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 66. AB Science Recent Development
    Table 67. BeiGene Company Details
    Table 68. BeiGene Business Overview
    Table 69. BeiGene Metastatic Prostate Cancer Treatment Product
    Table 70. BeiGene Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 71. BeiGene Recent Development
    Table 72. eFFECTOR Therapeutics Company Details
    Table 73. eFFECTOR Therapeutics Business Overview
    Table 74. eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Product
    Table 75. eFFECTOR Therapeutics Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 76. eFFECTOR Therapeutics Recent Development
    Table 77. Immunomedics(Gilead Sciences, Inc.) Company Details
    Table 78. Immunomedics(Gilead Sciences, Inc.) Business Overview
    Table 79. Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Product
    Table 80. Immunomedics(Gilead Sciences, Inc.) Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 81. Immunomedics(Gilead Sciences, Inc.) Recent Development
    Table 82. Myovant Biosciences Company Details
    Table 83. Myovant Biosciences Business Overview
    Table 84. Myovant Biosciences Metastatic Prostate Cancer Treatment Product
    Table 85. Myovant Biosciences Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 86. Myovant Biosciences Recent Development
    Table 87. SeleXel Company Details
    Table 88. SeleXel Business Overview
    Table 89. SeleXel Metastatic Prostate Cancer Treatment Product
    Table 90. SeleXel Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 91. SeleXel Recent Development
    Table 92. Zenith Epigenetics Ltd. Company Details
    Table 93. Zenith Epigenetics Ltd. Business Overview
    Table 94. Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Product
    Table 95. Zenith Epigenetics Ltd. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 96. Zenith Epigenetics Ltd. Recent Development
    Table 97. VasGene Therapeutics, Inc. Company Details
    Table 98. VasGene Therapeutics, Inc. Business Overview
    Table 99. VasGene Therapeutics, Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 100. VasGene Therapeutics, Inc. Recent Development
    Table 101. Telix Pharmaceuticals Company Details
    Table 102. Telix Pharmaceuticals Business Overview
    Table 103. Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Product
    Table 104. Telix Pharmaceuticals Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 105. Telix Pharmaceuticals Recent Development
    Table 106. Arvinas Inc. Company Details
    Table 107. Arvinas Inc. Business Overview
    Table 108. Arvinas Inc. Metastatic Prostate Cancer Treatment Product
    Table 109. Arvinas Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 110. Arvinas Inc. Recent Development
    Table 111. Amgen Company Details
    Table 112. Amgen Business Overview
    Table 113. Amgen Metastatic Prostate Cancer Treatment Product
    Table 114. Amgen Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 115. Amgen Recent Development
    Table 116. Genentech Company Details
    Table 117. Genentech Business Overview
    Table 118. Genentech Metastatic Prostate Cancer Treatment Product
    Table 119. Genentech Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
    Table 120. Genentech Recent Development
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Metastatic Prostate Cancer Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Mono Features
    Figure 3. Combination Features
    Figure 4. Mono/Combination Features
    Figure 5. Global Metastatic Prostate Cancer Treatment Market Share by Application: 2020 VS 2027
    Figure 6. Hospital Case Studies
    Figure 7. Drug Store Case Studies
    Figure 8. Online Pharmacy Case Studies
    Figure 9. Metastatic Prostate Cancer Treatment Report Years Considered
    Figure 10. Global Metastatic Prostate Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Metastatic Prostate Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Metastatic Prostate Cancer Treatment Market Share by Regions: 2020 VS 2027
    Figure 13. Global Metastatic Prostate Cancer Treatment Market Share by Regions (2022-2027)
    Figure 14. Global Metastatic Prostate Cancer Treatment Market Share by Players in 2020
    Figure 15. Global Top Metastatic Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Prostate Cancer Treatment as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Metastatic Prostate Cancer Treatment Revenue in 2020
    Figure 17. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2016-2021)
    Figure 18. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2022-2027)
    Figure 19. North America Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Metastatic Prostate Cancer Treatment Market Share by Type (2016-2027)
    Figure 21. North America Metastatic Prostate Cancer Treatment Market Share by Application (2016-2027)
    Figure 22. North America Metastatic Prostate Cancer Treatment Market Share by Country (2016-2027)
    Figure 23. United States Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Metastatic Prostate Cancer Treatment Market Share by Type (2016-2027)
    Figure 27. Europe Metastatic Prostate Cancer Treatment Market Share by Application (2016-2027)
    Figure 28. Europe Metastatic Prostate Cancer Treatment Market Share by Country (2016-2027)
    Figure 29. Germany Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Metastatic Prostate Cancer Treatment Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Metastatic Prostate Cancer Treatment Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Metastatic Prostate Cancer Treatment Market Share by Region (2016-2027)
    Figure 39. China Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Metastatic Prostate Cancer Treatment Market Share by Type (2016-2027)
    Figure 47. Latin America Metastatic Prostate Cancer Treatment Market Share by Application (2016-2027)
    Figure 48. Latin America Metastatic Prostate Cancer Treatment Market Share by Country (2016-2027)
    Figure 49. Mexico Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Metastatic Prostate Cancer Treatment Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Metastatic Prostate Cancer Treatment Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Metastatic Prostate Cancer Treatment Market Share by Country (2016-2027)
    Figure 55. Turkey Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. AB Science Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
    Figure 59. BeiGene Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
    Figure 60. eFFECTOR Therapeutics Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
    Figure 61. Immunomedics(Gilead Sciences, Inc.) Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
    Figure 62. Myovant Biosciences Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
    Figure 63. SeleXel Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
    Figure 64. Zenith Epigenetics Ltd. Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
    Figure 65. VasGene Therapeutics, Inc. Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
    Figure 66. Telix Pharmaceuticals Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
    Figure 67. Arvinas Inc. Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
    Figure 68. Amgen Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
    Figure 69. Genentech Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AB Science
BeiGene
eFFECTOR Therapeutics
Immunomedics(Gilead Sciences, Inc.)
Myovant Biosciences
SeleXel
Zenith Epigenetics Ltd.
VasGene Therapeutics, Inc.
Telix Pharmaceuticals
Arvinas Inc.
Amgen
Genentech
Frequently Asked Questions
Metastatic Prostate Cancer Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Metastatic Prostate Cancer Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Metastatic Prostate Cancer Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports